|
New research with Tamoxifen and Herceptin
Even though I am her2+ without hormonal receptors, I still think the work by Dr. DiGiovanna concerning the use of Tamoxifen in synegy with Herceptin is extremely interesting:
"Dr. DiGiovanna's hypothesis is that a combination of drugs that inhibit both the estrogen reception (ER) and the HER2 receptor proteins should be more effective and have fewer side effects than conventional chemotherapy. He has shown that cultures of breast cancer cells that have both ER and HER2 receptors grow much more slowly when treated with either Herceptin (specific for HER2) or tamoxifen (specific for ER). However, when both Herceptin and tamoxifen are added together, growth of the cancer cells stops altogether. Moving from cell culture into the treatment of mice with breast cancer, he has shown that either drug alone slowed the growth of breast tumors, but the combination inhibited growth best. He is now analyzing the tumors from the animals to determine the reason for the increased inhibition with the two-drug regimen. This research will provide a biological foundation for the treatment of women with ER- and HER2-positive breast cancer with a combination of HER2 and ER inhibitor drugs."
__________________
Robin
2002- dx her2 positive DCIS/bc TX Mast, herceptin chemo
|